75 related articles for article (PubMed ID: 12817877)
1. Detection and analysis of apoptosis in breast and ovarian cancer subjects--genetic studies.
Kozłowska E; Romanowicz-Makowska H; Zadrozny M; Mankiewicz J; Szyłło K; Pertyński T; Kulig A; Smolarz B
Pol J Pathol; 2003; 54(1):25-9. PubMed ID: 12817877
[TBL] [Abstract][Full Text] [Related]
2. Frequency analysis of apoptosis in sporadic breast cancer.
Kozłowska E; Smolarz B; Kulig A; Romanowicz-Makowska H
Pol J Pathol; 2006; 57(4):199-204. PubMed ID: 17285763
[TBL] [Abstract][Full Text] [Related]
3. Detection of circulating tumour cells in patients with breast or ovarian cancer by molecular cytogenetics.
Engel H; Kleespies C; Friedrich J; Breidenbach M; Kallenborn A; Schöndorf T; Kolhagen H; Mallmann P
Br J Cancer; 1999 Dec; 81(7):1165-73. PubMed ID: 10584878
[TBL] [Abstract][Full Text] [Related]
4. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
5. Primary and metastatic ovarian cancer in patients with prior breast carcinoma. Pre-operative markers and treatment results.
Tserkezoglou A; Kontou S; Hadjieleftheriou G; Apostolikas N; Vassilomanolakis M; Sikiotis K; Salamalekis E; Tseke P; Magiakos G
Anticancer Res; 2006; 26(3B):2339-44. PubMed ID: 16821613
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous apoptosis of blood dendritic cells in patients with breast cancer.
Pinzon-Charry A; Maxwell T; McGuckin MA; Schmidt C; Furnival C; López JA
Breast Cancer Res; 2006; 8(1):R5. PubMed ID: 16417648
[TBL] [Abstract][Full Text] [Related]
7. The roles of serum leptin concentration and polymorphism in leptin receptor gene at codon 109 in breast cancer.
Liu CL; Chang YC; Cheng SP; Chern SR; Yang TL; Lee JJ; Guo IC; Chen CP
Oncology; 2007; 72(1-2):75-81. PubMed ID: 18004080
[TBL] [Abstract][Full Text] [Related]
8. [mRNA expression of CK19 and CEA in peripheral blood of patients with breast cancer detected by real-time quantitative PCR].
Zheng HY; Chen Q; Ye YB; Huang WW
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2267-70. PubMed ID: 19087676
[TBL] [Abstract][Full Text] [Related]
9. Telomere length in human white blood cells remains constant with age and is shorter in breast cancer patients.
Levy T; Agoulnik I; Atkinson EN; Tong XW; Gause HM; Hasenburg A; Runnebaum IB; Stickeler E; Möbus VJ; Kaplan AL; Kieback DG
Anticancer Res; 1998; 18(3A):1345-9. PubMed ID: 9673338
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the time interval between diagnoses in women with double primary breast and ovarian or primary peritoneal cancers.
Olawaiye A; Caesar L; Walsh D; Lyman M; Yeh J; Rodabaugh K; Marchetti D; Lele S; Odunsi K
Gynecol Oncol; 2004 Sep; 94(3):796-802. PubMed ID: 15350375
[TBL] [Abstract][Full Text] [Related]
11. Hereditary breast/ovarian cancer: clinicopathological characteristics and survival of BRCA2 positive and negative cases.
Syamala V; Syamala VS; Sreeja L; Raveendran PB; Vijayalekshmi RV; Sheeja VR; Santhi S; Kuttan R; Abraham EK; Ankathil R
J Exp Ther Oncol; 2008; 7(3):227-36. PubMed ID: 19066131
[TBL] [Abstract][Full Text] [Related]
12. Germline NBS1 mutations in families with aggregation of Breast and/or ovarian cancer from north-east Poland.
Kanka C; Brozek I; Skalska B; Siemiatkowska A; Limon J
Anticancer Res; 2007; 27(4C):3015-8. PubMed ID: 17695489
[TBL] [Abstract][Full Text] [Related]
13. XPD Lys751Gln polymorphism analysis in women with sporadic breast cancer.
Romanowicz-Makowska H; Sobczuk A; Smolarz B; Fiks T; Kulig A
Pol J Pathol; 2007; 58(4):245-9. PubMed ID: 18459458
[TBL] [Abstract][Full Text] [Related]
14. Expression of the apoptotic markers in normal breast epithelium, benign mammary dysplasia and in breast cancer.
Koda M; Kanczuga-Koda L; Reszec J; Sulkowska M; Famulski W; Baltaziak M; Kisielewski W; Sulkowski S
Folia Morphol (Warsz); 2004 Aug; 63(3):337-41. PubMed ID: 15478112
[TBL] [Abstract][Full Text] [Related]
15. Association of disease progression and poor overall survival with detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer.
Bauernhofer T; Zenahlik S; Hofmann G; Balic M; Resel M; Pirchmoser R; Regitnig P; Ambros P; Dandachi N; Samonigg H
Oncol Rep; 2005 Feb; 13(2):179-84. PubMed ID: 15643496
[TBL] [Abstract][Full Text] [Related]
16. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of anti-apoptotic proteins in non-involved tissue from cancer-containing breasts.
Batchelder AJ; Gordon-Weeks AN; Walker RA
Breast Cancer Res Treat; 2009 Mar; 114(1):63-9. PubMed ID: 18368476
[TBL] [Abstract][Full Text] [Related]
18. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
Dulaimi E; Hillinck J; Ibanez de Caceres I; Al-Saleem T; Cairns P
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6189-93. PubMed ID: 15448006
[TBL] [Abstract][Full Text] [Related]
19. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
20. The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation.
Salceda S; Tang T; Kmet M; Munteanu A; Ghosh M; Macina R; Liu W; Pilkington G; Papkoff J
Exp Cell Res; 2005 May; 306(1):128-41. PubMed ID: 15878339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
